1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hemochromatosis Global Clinical Trials Review, H2, 2015

Hemochromatosis Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 72 pages

Hemochromatosis Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Hemochromatosis Global Clinical Trials Review, H2, 2015" provides an overview of Hemochromatosis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemochromatosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Hemochromatosis Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hemochromatosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hemochromatosis to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hemochromatosis to Genetic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hemochromatosis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hemochromatosis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Lipomed AG 33
Clinical Trial Overview of Lipomed AG 33
OPIS s.r.l. 34
Clinical Trial Overview of OPIS s.r.l. 34
Clinical Trial Overview of Top Institutes / Government 35
The Children's Hospital Los Angeles 35
Clinical Trial Overview of The Children's Hospital Los Angeles 35
Annamalai University 36
Clinical Trial Overview of Annamalai University 36
Boston Children's Hospital 37
Clinical Trial Overview of Boston Children's Hospital 37
Centre Hospitalier Universitaire de Rennes 38
Clinical Trial Overview of Centre Hospitalier Universitaire de Rennes 38
Innsbruck Medical University 39
Clinical Trial Overview of Innsbruck Medical University 39
King's College London 40
Clinical Trial Overview of King's College London 40
Maastricht University Medical Center 41
Clinical Trial Overview of Maastricht University Medical Center 41
Murdoch Childrens Research Institute 42
Clinical Trial Overview of Murdoch Childrens Research Institute 42
National Heart, Lung, and Blood Institute 43
Clinical Trial Overview of National Heart, Lung, and Blood Institute 43
St. Jude Children's Research Hospital, Inc. 44
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 44
Five Key Clinical Profiles 45
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72

List of Tables
Hemochromatosis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Hemochromatosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hemochromatosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hemochromatosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Hemochromatosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hemochromatosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hemochromatosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Hemochromatosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Hemochromatosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Hemochromatosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hemochromatosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hemochromatosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Hemochromatosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hemochromatosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hemochromatosis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Hemochromatosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Hemochromatosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hemochromatosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hemochromatosis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Hemochromatosis Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Hemochromatosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Hemochromatosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Hemochromatosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Hemochromatosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Hemochromatosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 32
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lipomed AG, 2015* 33
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by OPIS s.r.l., 2015* 34
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital Los Angeles, 2015* 35
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Annamalai University, 2015* 36
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2015* 37
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Rennes, 2015* 38
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innsbruck Medical University, 2015* 39
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by King's College London, 2015* 40
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2015* 41
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Murdoch Childrens Research Institute, 2015* 42
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015* 43
Hemochromatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2015* 44

List of Figures
Hemochromatosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Hemochromatosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hemochromatosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hemochromatosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Hemochromatosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hemochromatosis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Hemochromatosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Proportion of Hemochromatosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Hemochromatosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hemochromatosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hemochromatosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Hemochromatosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hemochromatosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hemochromatosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Hemochromatosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Hemochromatosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hemochromatosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hemochromatosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Hemochromatosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Hemochromatosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Hemochromatosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Hemochromatosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.